サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1669621

フィルフィニッシュ医薬品受託製造の世界市場レポート 2025年

Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
フィルフィニッシュ医薬品受託製造の世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フィルフィニッシュ医薬品受託製造の市場規模は今後数年で急成長が見込まれます。2029年には10.2%のCAGRで189億8,000万米ドルに成長します。予測期間の成長は、新たな市場機会、パンデミック対策、デジタルトランスフォーメーション、持続可能性と環境に配慮した取り組み、個別化医療の拡大に起因すると考えられます。予測期間の主な動向には、柔軟な製造ソリューション、提携と協力、規制遵守とシリアル化、持続可能性と環境に配慮した取り組みへの注力、自動化とロボットの統合などがあります。

フィルフィニッシュ医薬品受託製造市場の成長が期待される背景には、医薬品に対する需要の高まりがあります。これらの製品には、人間や動物の病気の診断、予防、治療、治癒を目的とした薬や医薬品が含まれます。フィルフィニッシュ医薬品受託製造は、注射剤、生物製剤、その他の医薬品の無菌充填に不可欠です。このサービスは、高い製品品質を維持しながら、精度、規制遵守、効率的な製造工程を保証します。例えば、2023年6月、欧州製薬団体連合会（EFPIA）は、欧州の医薬品総生産額が2021年の3,480億米ドル（3,239億5,000万ユーロ）から2022年には3,696億5,000万米ドル（3,400億ユーロ）に増加したと報告しました。その結果、医薬品需要の増加がフィルフィニッシュ医薬品受託製造市場の成長を牽引しています。

医薬品開発パイプラインの増加は、今後数年間のフィルフィニッシュ医薬品受託製造市場の成長を促進すると予想されます。医薬品開発パイプラインは、新しい医薬品や治療製品が最初の発見から市場開拓に至るまでの段階的なプロセスを包含しています。フィルフィニッシュ医薬品受託製造はこのパイプラインで、医薬品が滅菌され、バイアルやシリンジに充填され、密封され、ラベルが貼られる医薬品製造の最終段階をアウトソーシングするために利用されます。例えば、ベルギーを拠点とする欧州の製薬業界を代表する業界団体である欧州製薬団体連合会（European Federation of Pharmaceutical Industries and Associations）は2024年、世界の研究開発パイプラインが2022年の3,633億米ドルから2023年には3,900億米ドルに増加したと報告し、医薬品の研究開発における投資と進歩の増加を強調しています。このように、フィルフィニッシュ医薬品開発パイプラインの成長が医薬品受託製造市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のフィルフィニッシュ医薬品受託製造PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界のフィルフィニッシュ医薬品受託製造市場：成長率分析
  • 世界のフィルフィニッシュ医薬品受託製造市場の実績：規模と成長, 2019-2024
  • 世界のフィルフィニッシュ医薬品受託製造市場の予測：規模と成長, 2024-2029, 2034F
  • 世界のフィルフィニッシュ医薬品受託製造総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のフィルフィニッシュ医薬品受託製造市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • プレフィルドシリンジ
  • バイアル
  • カートリッジ
  • その他の製品
  • 世界のフィルフィニッシュ医薬品受託製造市場：分子タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 巨大分子
  • 小分子
  • 世界のフィルフィニッシュ医薬品受託製造市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バイオ医薬品企業
  • 製薬会社
  • 世界のフィルフィニッシュ医薬品受託製造市場、タイプ別サブセグメンテーション：プレフィルドシリンジ、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ガラスプレフィルドシリンジ
  • プラスチックプレフィルドシリンジ
  • 世界のフィルフィニッシュ医薬品受託製造市場、タイプ別サブセグメンテーション：バイアル、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ガラスバイアル
  • プラスチックバイアル
  • 世界のフィルフィニッシュ医薬品受託製造市場、タイプ別サブセグメンテーション：カートリッジ、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ガラスカートリッジ
  • プラスチックカートリッジ
  • 世界のフィルフィニッシュ医薬品受託製造市場、タイプ別サブセグメンテーション：その他の製品、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アンプル
  • ブリスター
  • パウチ

第7章 地域別・国別分析

  • 世界のフィルフィニッシュ医薬品受託製造市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のフィルフィニッシュ医薬品受託製造市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医薬品受託製造市場：競合情勢
  • 医薬品受託製造市場：企業プロファイル
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Eurofins Scientific SE
  • Lonza Group Ltd.
  • Catalent Inc.
  • Sun Pharmaceutical Industries Limited
  • West Pharmaceutical Services Inc.
  • Patheon
  • Samsung Biologics Co. Ltd.
  • WuXi Biologics
  • Piramal Pharma Solutions
  • Pfizer CentreOne
  • Recipharm AB
  • Emergent BioSolutions Inc.
  • Boehringer Ingelheim BioXcellence
  • Corden Pharma GmbH
  • Aenova Group

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 医薬品受託製造市場2029：新たな機会を提供する国
  • 医薬品受託製造市場2029：新たな機会を提供するセグメント
  • 医薬品受託製造市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r24925

Fill-finish pharmaceutical contract manufacturing involves outsourcing the final stages of the pharmaceutical manufacturing process to specialized contract manufacturing organizations (CMOs).

The primary product types in fill-finish pharmaceutical contract manufacturing include prefilled syringes, vials, cartridges, and other products. Prefilled syringes are pre-loaded with a specific dose of medication, ensuring precise dosing, sterility, and quality control through the aseptic fill-finish pharmaceutical contract manufacturing processes. This outsourcing approach is employed for both large molecules and small molecules, with biopharmaceutical companies and pharmaceutical companies serving as the key end-users.

The fill-finish pharmaceutical contract manufacturing research report is one of a series of new reports from The Business Research Company that provides fill-finish pharmaceutical contract manufacturing market statistics, including the fill-finish pharmaceutical contract manufacturing industry's global market size, regional shares, competitors with a fill-finish pharmaceutical contract manufacturing market share, detailed fill-finish pharmaceutical contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the fill-finish pharmaceutical contract manufacturing industry. This fill-finish pharmaceutical contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fill-finish pharmaceutical contract manufacturing market size has grown strongly in recent years. It will grow from $11.84 billion in 2024 to $12.86 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing demand for biologics, outsourcing trends, globalization of pharmaceutical supply chains, quality assurance emphasis, cost containment measures

The fill-finish pharmaceutical contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $18.98 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to emerging market opportunities, pandemic preparedness, digital transformation, sustainability and green initiatives, personalized medicine expansion. Major trends in the forecast period include flexible manufacturing solutions, partnerships and collaborations, regulatory compliance and serialization, focus on sustainability and green practices, automation and robotics integration.

The expected growth in the fill-finish pharmaceutical contract manufacturing market is fueled by the rising demand for pharmaceutical products. These products include medications or drugs designed to diagnose, prevent, treat, or cure diseases in humans or animals. Fill-finish pharmaceutical contract manufacturing is crucial for aseptically filling injectables, biologics, and other pharmaceutical items. This service guarantees precision, regulatory compliance, and efficient manufacturing processes while maintaining high product quality. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total pharmaceutical production in Europe grew from $348 billion (€323.95 billion) in 2021 to $369.65 billion (€340 billion) in 2022. As a result, the increasing demand for pharmaceutical products is driving the growth of the fill-finish pharmaceutical contract manufacturing market.

The increasing drug development pipeline is anticipated to drive the growth of the fill-finish pharmaceutical contract manufacturing market in the coming years. The drug development pipeline encompasses the step-by-step process that a new pharmaceutical or therapeutic product undergoes, from initial discovery to market availability. Fill-finish pharmaceutical contract manufacturing is utilized in this pipeline to outsource the final stages of drug production, where the drug product is sterilized, filled into vials or syringes, sealed, and labeled. For example, in 2024, the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association representing the pharmaceutical industry in Europe, reported that the global research and development pipeline increased from $363.3 billion in 2022 to $390 billion in 2023, highlighting a rise in investments and advancements in pharmaceutical research and development. Thus, the growth in the drug development pipeline is fueling the expansion of the fill-finish pharmaceutical contract manufacturing market.

Technological advancements emerge as a prominent trend in the fill-finish pharmaceutical contract manufacturing market. Companies within this sector are embracing innovative technologies to elevate product quality and adhere to stringent regulatory standards, ensuring their competitive position. For instance, in January 2023, Steriline s.r.l., an Italy-based provider specializing in aseptic solutions, introduced robotic technologies tailored for small-batch aseptic filling in January 2023. These robotic systems enhance safety and flexibility in producing both toxic and non-toxic pharmaceutical drugs, minimizing the risk of human error, improving product quality, and optimizing operational efficiency.

Leading companies in the fill-finish pharmaceutical contract manufacturing market prioritize the integration of cutting-edge capabilities such as lyophilization technologies. Lyophilization capabilities involve a facility's expertise in the lyophilization process, or freeze-drying, which is crucial for drying and preserving biological or pharmaceutical products by removing water content through sublimation. In February 2022, Recro Pharma, Inc., a US-based contract development and manufacturing organization (CDMO), introduced Lyophilization Aseptic Fill/Finish to its range of services. This suite includes a sterile, automated vial filling system capable of filling up to 2,000 pre-sterilized vials per hour across various volumes. The equipment can lyophilize approximately 9,000 10 mL vials in each freeze-drying cycle, typically spanning 3-5 days.

In March 2024, AstraZeneca, a biopharmaceutical company based in England, acquired Amolyt Pharma, enhancing its late-stage pipeline for rare diseases for an undisclosed amount. This acquisition aims to strengthen AstraZeneca's ability to develop innovative treatments for underserved patient populations, especially in the areas of rare endocrine and metabolic disorders. Amolyt Pharma, located in France, specializes in creating advanced therapeutics for individuals with rare endocrine and metabolic diseases.

Major companies operating in the fill-finish pharmaceutical contract manufacturing market include AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi, Abbott Laboratories, Eurofins Scientific SE, Lonza Group Ltd., Catalent Inc., Sun Pharmaceutical Industries Limited, West Pharmaceutical Services Inc., Patheon, Samsung Biologics Co.Ltd., WuXi Biologics, Piramal Pharma Solutions, Pfizer CentreOne, Recipharm AB, Emergent BioSolutions Inc., Boehringer Ingelheim BioXcellence, Corden Pharma GmbH, Aenova Group, Baxter BioPharma Solutions, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Rentschler Biopharma SE, Recro Pharma Inc., Cobra Biologics Limited, Grand River Aseptic Manufacturing (GRAM), MabPlex International Ltd., Cerbios-Pharma SA, Symbiosis Pharmaceutical Services Limited

North America was the largest region in the fill-finish pharmaceutical contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fill-finish pharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fill-finish pharmaceutical contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fill-finish pharmaceutical contract manufacturing market includes revenues earned by entities by providing septic filling, packaging, labeling, and serialization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fill-Finish Pharmaceutical Contract Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fill-finish pharmaceutical contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fill-finish pharmaceutical contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fill-finish pharmaceutical contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Prefilled Syringes; Vials; Cartridges; Other Products
  • 2) By Molecule Type: Large Molecules; Small Molecules
  • 3) By End-User: Biopharmaceutical Companies; Pharmaceutical Companies
  • Subsegments:
  • 1) By Prefilled Syringes: Glass Prefilled Syringes; Plastic Prefilled Syringes
  • 2) By Vials: Glass Vials; Plastic Vials
  • 3) By Cartridges: Glass Cartridges; Plastic Cartridges
  • 4) By Other Products: Ampoules; Blisters; Pouches
  • Companies Mentioned: AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Fresenius Kabi; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fill-Finish Pharmaceutical Contract Manufacturing Market Characteristics

3. Fill-Finish Pharmaceutical Contract Manufacturing Market Trends And Strategies

4. Fill-Finish Pharmaceutical Contract Manufacturing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Fill-Finish Pharmaceutical Contract Manufacturing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Fill-Finish Pharmaceutical Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Growth Rate Analysis
  • 5.4. Global Fill-Finish Pharmaceutical Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Fill-Finish Pharmaceutical Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Fill-Finish Pharmaceutical Contract Manufacturing Total Addressable Market (TAM)

6. Fill-Finish Pharmaceutical Contract Manufacturing Market Segmentation

  • 6.1. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prefilled Syringes
  • Vials
  • Cartridges
  • Other Products
  • 6.2. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Large Molecules
  • Small Molecules
  • 6.3. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • 6.4. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Sub-Segmentation Of Prefilled Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes
  • 6.5. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Sub-Segmentation Of Vials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glass Vials
  • Plastic Vials
  • 6.6. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Sub-Segmentation Of Cartridges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glass Cartridges
  • Plastic Cartridges
  • 6.7. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ampoules
  • Blisters
  • Pouches

7. Fill-Finish Pharmaceutical Contract Manufacturing Market Regional And Country Analysis

  • 7.1. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Fill-Finish Pharmaceutical Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 8.1. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 9.1. China Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 9.2. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 10.1. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 11.1. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 11.2. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 12.1. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 13.1. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 14.1. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 14.2. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 15.1. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 15.2. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 16.1. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 17.1. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 18.1. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 19.1. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 20.1. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 21.1. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 21.2. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 22.1. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 23.1. North America Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 23.2. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 24.1. USA Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 24.2. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 25.1. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 25.2. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 26.1. South America Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 26.2. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 27.1. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 28.1. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 28.2. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market

  • 29.1. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market Overview
  • 29.2. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By Molecule Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Fill-Finish Pharmaceutical Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Landscape And Company Profiles

  • 30.1. Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Landscape
  • 30.2. Fill-Finish Pharmaceutical Contract Manufacturing Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Fill-Finish Pharmaceutical Contract Manufacturing Market Other Major And Innovative Companies

  • 31.1. Eurofins Scientific SE
  • 31.2. Lonza Group Ltd.
  • 31.3. Catalent Inc.
  • 31.4. Sun Pharmaceutical Industries Limited
  • 31.5. West Pharmaceutical Services Inc.
  • 31.6. Patheon
  • 31.7. Samsung Biologics Co. Ltd.
  • 31.8. WuXi Biologics
  • 31.9. Piramal Pharma Solutions
  • 31.10. Pfizer CentreOne
  • 31.11. Recipharm AB
  • 31.12. Emergent BioSolutions Inc.
  • 31.13. Boehringer Ingelheim BioXcellence
  • 31.14. Corden Pharma GmbH
  • 31.15. Aenova Group

32. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fill-Finish Pharmaceutical Contract Manufacturing Market

34. Recent Developments In The Fill-Finish Pharmaceutical Contract Manufacturing Market

35. Fill-Finish Pharmaceutical Contract Manufacturing Market High Potential Countries, Segments and Strategies

  • 35.1 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Fill-Finish Pharmaceutical Contract Manufacturing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer